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ABSTRACT
Background: The aim of this study was to determine the presence of alterations in the natriuretic systems of atrial natriuretic 
peptide and renal dopamine in a model of metabolic syndrome induced by fructose overload and to associate them with changes in 
systolic blood pressure, renal function, Na+/K+-ATPase status and microalbuminuria. 
Methods: Male Sprague-Dawley rats were divided into control (C) and fructose (F) groups receiving drinking water or a fructose so-
lution (10% W/V), respectively, for 4, 8 and 12 weeks. L-dopa and dopamine, sodium, creatinine and albumin were measured in urine 
and ANP, insulin, sodium and creatinine in plasma. Systolic blood pressure was measured by indirect method and the renal activity 
and expression of Na+/K+-ATPase as well as the renal expression of A- and C-type natriuretic peptide receptors were assessed.
results: Fructose overload was associated with a significant increase in insulinemia and systolic blood pressure levels and a decrease 
in urinary sodium excretion since week 4. A significant increase in L-dopa excretion and a decrease in dopamine excretion (increased 
urinary L-dopa/dopamine ratio) due to fructose overload were observed since week 4 with a decrease in plasma atrial natriuretic 
peptide at weeks 8 and 12. These changes were accompanied by increased activity and expression of Na+/ K+-ATPase, decreased 
A-type natriuretic peptide receptor and increased C-type natriuretic peptide receptor expression. Microalbuminuria was observed 
at week 12 of fructose overload. 
Conclusions: Altered atrial natriuretic peptide and renal dopamine were associated with the development of hypertension and pre-
ceded in time the presence of microalbuminuria, thus establishing a temporal association between the alteration of both systems 
and the development of renal damage.
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RESUMEN
Objetivos: El objetivo del trabajo consistió en determinar la existencia de alteraciones en los sistemas natriuréticos del péptido 
natriurético atrial y dopamina renal en un modelo de síndrome metabólico por sobrecarga de fructosa y asociarlas con cambios en la 
presión arterial sistólica, función renal, estado de la Na+, K+-ATPasa y microalbuminuria. 
Material y Métodos: Ratas macho Sprague-Dawley fueron divididas en grupos control (C) y fructosa (F) con agua o solución de F 
(10%P/V) para beber durante 4, 8 y 12 semanas. En orina, se midió L-dopa y dopamina, sodio, creatinina y albúmina; y en plasma 
péptido natriurético atrial, insulina, sodio y creatinina. La presión arterial sistólica fue medida por método indirecto. Se midió la 
actividad y expresión de la Na+, K+-ATPasa así como la expresión del receptor de péptidos natriuréticos A y C renales. 
resultados: La sobrecarga de fructosa se asoció con el aumento de la insulinemia y la presión arterial sistólica, y con la disminución 
en la excreción urinaria de sodio desde la semana 4. La excreción urinaria de L-dopa se incrementó y la de dopamina disminuyó 
(cociente L-dopa/dopamina incrementado) por sobrecarga de fructosa desde la semana 4 y el péptido natriurético atrial plasmático 
se redujo en las semanas 8 y 12. Estos cambios fueron acompañados por un incremento de la actividad y expresión de la Na+, K+-
ATPasa, disminución del receptor de péptidos natriuréticos A y aumento del C. La microalbuminuria se observó en la semana 12 de 
sobrecarga de fructosa.
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7INTRODUCTION
Hypertension is the most prevalent chronic disease 
with worldwide incidence and one of the cardiovascular 
risk factors that takes part in the definition of meta-
bolic syndrome. (1, 2) It has been shown that altered 
renal excretion of sodium has vital importance in the 
pathogenesis of hypertension. (3) Renal dopamine and 
the atrial natriuretic peptide (ANP) are two natriuretic 
systems capable of modifying renal sodium manage-
ment through the regulation of various sodium ion 
transporters in tubular cells. (3, 4) Among these cells, 
proximal tubular cells are able to synthesize dopamine 
from the uptake and subsequent decarboxylation of the 
L-dopa precursor by dopa decarboxylase. (5) Under ba-
sal conditions, more than 50% of the renal excretion of 
sodium is regulated by the activation of dopamine- me-
diated D1 receptors. (6) On the other hand, ANP exerts 
its natriuretic action by activating the A-type natriu-
retic peptide receptor (NPRA) in the kidneys. (7) The 
atrial natriuretic peptide can also bind to the C-type 
natriuretic peptide receptor (NPRC), which is consid-
ered a clearing receptor that mediates the degradation 
of this peptide. (8) During the last decade, numerous 
studies have suggested the possible existence of an in-
teraction between natriuretic peptides and the renal 
dopaminergic system. (9, 10). In this sense, it has been 
reported that renal dopamine and ANP can achieve 
their natriuretic effects through a common pathway 
that involves the reversible deactivation of renal Na+/
K+-ATPase, an enzyme whose alteration is closely re-
lated to saline retention. (11, 12) 
On the other hand, it is estimated that about 30-
50% of hypertensive patients have insulin resistance. 
(1, 13) Several studies have established an association 
between insulin resistance and alterations in the renal 
dopaminergic system in the genesis of hypertension. 
(14) It has been demonstrated that rats with insulin-
resistance due to fructose overload (FO) have lower 
urinary excretion of dopamine, which inversely cor-
relates with blood pressure levels. (15) Likewise, sev-
eral studies have confirmed a correlation between low 
levels of ANP and high levels of glucose and insulin, 
as well as of cholesterol and plasma triglycerides. (16, 
17) However, there is little evidence about the interac-
tion between renal dopamine and ANP in the physi-
opathology of hypertension induced by a high fructose 
diet. Moreover, the kidney is one of the target organs 
of hypertension, and microalbuminuria is currently 
an early indicator of nephropathy and a predictor of 
ischemic heart disease in essential hypertension. (18) 
In this context, the association between metabolic 
syndrome, insulin resistance and renal damage has 
been demonstrated. (19, 20) 
The aim of this work was to determine whether 
alterations in the natriuretic systems of ANP and 
renal dopamine in insulin-resistant rats due to high 
fructose diet are associated with changes in systolic 
blood pressure and renal tubular function, increased 
activity or expression of renal Na+/K+-ATPase and 
the presence of microalbuminuria as a marker of re-
nal structural damage.
METHODS
experimental animals 
Male Sprague-Dawley rats weighing 150 to 180 g were used, 
with 12:12 h light/dark cycles, at 22ºC, and fed with a bal-
anced diet for rodents. 
Systolic blood pressure assessment
The animals were trained three times a week in the proce-
dure of blood pressure assessment. Systolic blood pressure 
(SBP) was determined before beginning the study and at 
the end of each experimental period through indirect ple-
thysmographic method by means of a sphygmomanometer 
in the rat tail, using an inflatable cuff and a microphone 
connected to a Grass DC amplifier (model 7DAC, Grass In-
struments Co.) coupled to a polygraph (model 79D, Grass 
Instruments Co.).
Collection and processing of urine and blood samples 
At the end of each experimental period, 24-hour urine sam-
ples were collected from the animals housed in metabolic 
cages, to determine 24-hour urine output and the urinary 
excretion of sodium, creatinine, albumin, L-dopa and dopa-
mine. Before sacrifice and under intraperitoneal anesthesia 
with ketamine (80 mg/kg) and xylazine (12 mg/kg), blood 
samples were collected from the retroocular plexus and 
centrifuged at 2700 rpm for 20 minutes at 4°C. Plasma and 
anP   Atrial natriuretic peptide
C   Control group 
ClCr   Creatinine clearance 
F   Fructose overload group
HrlC   High-resolution liquid chromatography 
nBCe1  Type 1 Na+-HCO3− cotransporter 
nHe3   Type 3 Na+/H+ exchanger 
nPra   A-type natriuretic peptide receptor 
nPrC   C-type natriuretic peptide receptor 
PKG   Protein kinase G 
SBP   Systolic blood pressure 
SF   Fructose overload
UnaV   Urinary sodium excretion.
abbreviations 
Conclusiones: Las alteraciones del péptido natriurético atrial y de la dopamina renal se asociaron con el desarrollo de hipertensión 
arterial y precedieron a la aparición de microalbuminuria, por lo que se pudo establecer una asociación temporal entre la alteración 
de ambos sistemas y el desarrollo de daño renal.
Palabras clave: Dopamina - Péptido natriurético atrial - Riñón - Fructosa - Hipertensión – Microalbuminuria
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urinary concentrations of sodium, creatinine and albumin 
were determined in an automated autoanalyzer (Spectrum 
CCX automated analyzer, diagnostic Abbott) by spectropho-
tometric method. Plasma insulin levels were determined by 
ELISA (Millipore Corporation) and plasma levels of ANP by 
ELISA (R & D Systems), after extraction by reverse phase 
chromatography with Sep-Pak C18 cartridges, according to 
the purification methodology of Sarda et al. (21) 
l-dopa and dopamine concentration assessment
Assessment of the urinary concentration of L-dopa and do-
pamine was performed by stabilization with 1 M acetic acid 
(pH 6.10), recovery in alumina and separation by reversed-
phase high-performance liquid chromatography (RP-HPLC) 
using 4.6 mm × 25 cm columns (Beckman Instruments). 
Catecholamines were quantified by amperometric detection 
with 0.65 V Bioanalytical Systems electrode versus Ag/Ag 
reference electrodes.
renal function parameter assessment 
Plasma and urinary sodium and creatinine values were used 
to assess renal function parameters. Glomerular filtration 
rate was estimated by creatinine clearance and tubular func-
tion by urinary sodium excretion. 
renal tissue collection and processing 
Immediately after sacrifice, both kidneys were removed 
from each animal and decapsulated. Sections of both kidneys 
were obtained and stored at -80ºC for western blot analyses 
and specific activity of Na+/K+-ATPase. 
Protein expression analysis by western blot technique
Protein expression was semiquantitatively analyzed using 
western blot technique, as previously described. (22) Renal 
expression of Na+/K+-ATPase was determined using anti- 
Na+/K+-ATPase antibody (Amersham, dilution 1: 8000), 
renal expression of NPRA, using anti-NPRA antibody (San-
ta Cruz Biotechnology, dilution 1: 7500), and expression of 
NPRC, using anti-NPRC antibody (Santa Cruz Biotechnol-
ogy, dilution 1: 400). Biotinylated IgG anti-rabbit antibody 
(GE Healthcare Life Sciences, dilution 1: 2000) and strepta-
vidin conjugated with radish peroxidase (GE Healthcare Life 
Sciences, dilution of 1: 2000) were used for secondary and 
tertiary reactions, respectively. The samples were revealed 
by chemiluminescence using ECL reagent (Amersham Phar-
macia Biotech). The density of the bands was quantified 
with Image J software (RSB). Anti-GAPDH antibody was 
used as internal standard loading control (Santa Cruz Bio-
technology, dilution 1: 1500). 
na+/K+-aTPase specific activity analysis 
Fifty mg samples of renal cortex were homogenized (1:10 
weight/volume) in a solution containing 25 mM imidazole/1 
mM EDTA/0.25 M sucrose and centrifuged at 4700 g at 4°C 
for 15 minutes. ATPase activity was measured by colorimet-
ric determination of the released orthophosphate and oua-
bain was used to specifically inhibit the Na+/K+-ATPase ac-
tivity according to Fiske-Subarrow’s method, as previously 
described. (22) 
Statistical analysis 
The data were processed with the GraphPad Prism pro-
gram, version 2.0. Gaussian distribution was evaluated by 
the Kolmogorov and Smirnov method and ANOVA followed 
by Newman-Keuls or Tukey tests was used to compare be-
tween the groups, as appropriate. Results were expressed as 
mean±SEM. Results with p<0.05 were considered statisti-
cally significant.
ethical considerations
All the experiments were carried out in accordance with the 
ethical norms of international regulations and the principles 
of care and use of experimental animals (protocol approved 
by CICUAL with Res. CD 2100-15, EXP-UBA: 0035638/15). 
At the beginning of the study rats were randomly assigned 
to 2 groups: a control group (C) with ad libitum tap water 
and a fructose group (F) with fructose (at 10% W/V) in the 
ad libitum drinking water for 4, 8 and 12 weeks (n=8 rats 
per group and period). 
 
RESULTS
Metabolic, hemodynamic and renal function parameters
Plasma insulin values were significantly increased 
by the high fructose diet compared with control rats 
since week 4 of treatment, indicating presence of hy-
perinsulinemia (Table 1). Similarly, SBP values were 
significantly increased in the rats with high fructose 
diet compared with control rats since week 4 of treat-
ment (Table 1). In the kidneys, fructose overload in 
the diet was associated with a significant increase 
in diuresis, as well as a reduction in sodium urinary 
excretion compared with control rats since week 4 of 
treatment (Table 1). Creatinine clearance was not sig-
nificantly modified by fructose treatment in any ex-
perimental period. The presence of microalbuminuria 
as a marker of renal damage was observed in week 12 
of fructose treatment (Table 1). 
renal dopaminergic system
A significant reduction in urinary dopamine excretion 
together with an increase of L-dopa excretion was ob-
served in rats with high fructose diet compared with 
the control groups since week 4 of treatment. These 
changes caused a significant increase in the L-dopa/
urinary dopamine ratio since the same week (Table 
1). A positive correlation was found between SBP and 
L-dopa/urinary dopamine ratio during the 12-week 
study period (R2=0.7816, p=0.002). 
Specific activity and expression of renal na+/K+-aTPase
The specific activity of renal Na+/K+-ATPase was 
significantly increased since week 4 of fructose treat-
ment with respect to control rats (Table 1). The in-
crease in activity was accompanied by an increase in 
protein expression by western blot (Figure 1). 
anP system 
A significant decrease in plasma ANP concentration 
was observed in rats with high fructose diet at weeks 
8 and 12 of treatment (Figure 2). In the kidneys, a 
decrease in NPRA expression was found since week 8 
(Figure 3) together with an increase in NPRC expres-
sion since week 4 of treatment (Figure 4). 
DISCUSSION
Metabolic syndrome is an entity that comprises a set 
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of disorders or metabolic abnormalities considered 
risk factors for the development of diabetes and cardi-
ovascular disease. (1) It has been shown that rats fed a 
high fructose diet exhibit a large number of metabolic 
syndrome characteristics, such as insulin resistance, 
hyperinsulinemia and high blood pressure. (23) In 
our experiments, rats with a high fructose diet pre-
sented hyperinsulinemia, indicating the existence of 
insulin-resistance. The increase in SBP was detected 
after week 4 of fructose treatment and reached the 
highest blood pressure values at 8 and 12 weeks, with 
levels close to 160 mmHg. Systolic blood pressure lev-
els were associated with a decrease in urinary sodium 
excretion since the same week, reflecting the state of 
saline retention in this experimental model. Although 
the exact mechanism by which hypertension develops 
in insulin-resistance conditions is still unknown, some 
studies suggest that hyperinsulinemia could cause so-
dium retention and an increase in sympathetic activ-
ity, key factors in the development of this disease. (24) 
Other authors suggest that the increase in renal re-
absorption of sodium induced by insulin is enhanced 
Na+/K+-ATPase
GAPDH
Time (weeks)
N
a+
/K
+
-A
TP
as
e 
O
D
/G
A
PD
H
 O
D
 (
U
A
)
Fructose (10% w/v) was administered in the ad libitum drinking water. Values are indicated 
as mean ± SEM (n=8 animals per group). C: Control; F: Fructose. * p <0.05 vs. C group.
Fig. 1. Protein expression of renal 
Na+/K+-ATPase in control and high 
fructose diet rats at 4, 8 and 12 weeks 
of treatment.
Fructose (10% w/v) was administered in the ad libitum drinking water. Values are indicated as mean ± SEM (n=8 animals per group). C: Control; F: 
Fructose; SBP: Systolic blood pressure; CrCl: Creatinine clearance, UNaV: Urinary sodium excretion. * p <0.05 vs. C; #p <0.01 vs. C.
Week 4 Week 8 Week 12
C C CF F F
insulinemia (mUi/l)
sBp (mmHg)
Diuresis (ml/day)
crcl (ml/min)
UnaV (meq/day)
l-dopa (ng/day)
Dopamine (ng/day)
l-dopa/dopamine
Albumin/creatinine (mg/g)
na+/K+-Atpase activity 
(µmol/g/s)
4.84 ± 0.48
118±3
11.80 ± 1.42
1.35 ± 0.17
1.01 ± 0.05
751 ±31
1,539 ± 58
0.49 ± 0.05
6.84 ± 0.50
2.00 ± 0.20
7.63 ± 0.95
121±1
15.63 ± 1.81
1.64 ± 0.25
1.02 ± 0.08
1,233 ± 33
2,304 ± 83
0.54 ± 0.06
10.80 ± 1.02
2.07 ± 0.27
7.57 ± 1.85
123±2
14.68 ± 1.60
1.59 ± 0.15
1.04 ± 0.08
1,042 ± 123
1,930 ± 35
0.54 ± 0.07
13.11 ± 1.4
2.33 ± 0.30
8.36 ± 1.23*
143±1*
24.52 ± 2.05*
1.49 ± 0.13
0.83 ± 0.04*
988 ±55*
520 ±25#
1.90 ± 0.09#
9.62 ± 1.01
2.87 ± 0.27*
12.67 ± 1.85*
160±8#
30.93 ± 2.90*
1.66 ± 0.12
0.73 ± 0.05#
1,732 ± 76*
735 ± 97#
2.36 ± 0.10#
6.85 ± 0.70
3.10 ± 0.28*
12.94 ± 2.00*
162±5#
30.63±2.67*
1.59±0.12
0.64±0.04#
2,169 ±123#
844 ±133#
2.57 ±0.20#
57.6 ± 2.5#
3.72 ± 0.35#
Table 1. Effects of fructose treatment on metabolic, hemodynamic and renal parameters at 4, 8 and 12 weeks of treatment
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Fig. 2. Plasma ANP levels in control 
and high fructose diet rats at 4, 8 
and 12 weeks of treatment.
Fig. 3. A-type natriuretic peptide 
receptor protein expression in the 
kidneys of control and high fructose 
diet rats at 4, 8 and 12 weeks of 
treatment.
in insulin resistance. Insulin stimulates all sodium 
transporters located in the proximal tubules, among 
them the Na+/K+-ATPase pump, the type 3 Na+/H+ 
exchanger (NHE3), and the electrogenic basolateral 
cotransporter Na+/HCO3-(NBCe1). (24) In our mod-
el, an increase in the specific activity of Na+/K+-AT-
Pase enzyme was observed since week 4 of treatment, 
accompanied by an increase in its protein expression 
by western blot. These data are supported by other 
studies showing that Na+/K+-ATPase is stimulated 
in insulin-resistance conditions and chronic exposure 
of renal cells to increased plasma insulin, which leads 
to greater sodium and water reabsorption, and, there-
fore, greater saline retention. (25)  
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Fructose (10% w/v) was administered in the ad libitum drinking water. Values are indicated 
as mean ± SEM (n=8 animals per group). C: Control; F: Fructose; NPRA: A-type natriuretic 
peptide receptor. * p <0.05 vs. C group.
Fructose (10% w/v) was administered in the ad libitum drinking water. Values are indicated 
as mean ± SEM (n=8 animals per group). C: Control; F: Fructose; ANP: Atrial natriuretic 
peptide. * p <0.05 vs. C group.
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A high fructose diet was associated with altera-
tions in the natriuretic systems of renal dopamine 
and ANP. Regarding the renal dopaminergic system, 
a progressive increase in urinary L-dopa/ dopamine 
ratio was observed after week 4 of treatment, at the 
expense of an increase in the urinary excretion of L-
dopa and a reduction of dopamine excretion. These 
changes would indicate the presence of reduced tubu-
lar uptake of L-dopa, a deficit of L-dopa conversion 
into dopamine in the tubular cells or a modification 
in the tubular release of the amine. In this sense, it 
has been shown that insulin stimulates the process of 
tubular L-dopa uptake and that this effect is abolished 
in rat models with insulin resistance due to fructose 
overload. (26) In another model of obesity-induced 
hyperinsulinemia, the presence of insulin resistance 
together with an increase in sympathetic tone was 
associated with lower renal dopaminergic activity. 
(27) The increase in urinary L-dopa/ dopamine ratio 
showed a positive correlation with the increase in SBP, 
thus being an adequate parameter that accompanies 
the increase in blood pressure levels in this model. 
Conversely, the ANP plasma concentration was sig-
nificantly reduced since week 8 in rats with fructose 
overload, accompanied by a decrease in NPRA recep-
tor expression. These results are consistent with the 
literature, where an association between low ANP 
levels, reduction in NPRA expression and states of in-
sulin-resistance has been demonstrated. (16, 17, 28) A 
possible explanation for the reduction in plasma ANP 
concentration would be an increase in its degradation 
by NPRC receptors. In our study, NPRC expression 
was increased in the kidneys. In models of obesity 
and insulin resistance, the increased levels of NPRC 
described in adipose tissue would be responsible for 
the reduction of natriuretic peptide plasma levels in 
these conditions. (28) Likewise, the alteration of both 
natriuretic systems preceded in time the presence 
of microalbuminuria as a marker of renal structural 
damage in week 12; therefore, it can be postulated 
that the alteration of these systems would be associ-
ated with damage in this organ. Regarding this point, 
it has been described that renal dopamine regulates 
the inflammatory and oxidative condition through its 
D2 receptors, with an increase in proinflammatory 
and oxidative stress markers in models with receptor 
deficiency. (29) Additionally, it has been shown that 
ANP has antioxidant effects in rats by attenuating the 
levels of reactive oxygen species in a model of renal 
damage by ischemia-reperfusion. (30) 
Our laboratory has shown that ANP stimulates 
dopamine uptake by tubular kidney cells, through the 
stimulation of NPRA receptors and protein kinase G 
(PKG) activation. (11, 12, 22) Moreover, it has been 
shown that ANP increases the synthesis of renal 
dopamine by stimulating the activity of dopa decar-
boxylase. (31) In this insulin-resistance model, and 
as a result of low levels of plasma ANP, a reduction 
in both synthesis and uptake of dopamine by tubular 
cells would be expected as a consequence of reduced 
Fig. 4. C-type natriuretic peptide 
receptor protein expression in the 
kidneys of control and high fructose 
diet rats at 4, 8 and 12 weeks of 
treatment.
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Fructose (10% w/v) was administered in the ad libitum drinking water. Values are indicated 
as mean ± SEM (n=8 animals per group). C: Control; F: Fructose; NPRC: C -type natriuretic 
peptide receptor * p <0.05 vs. C group.
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NPRA receptor expression in the kidneys. These ef-
fects would explain the decrease in the urinary excre-
tion of dopamine and, therefore, the increase in the 
L-dopa/dopamine ratio observed in our experiments. 
The results of the present work provide new evi-
dence of the interaction between ANP and renal do-
pamine systems, so an association can be established 
between the reduction in urinary excretion of dopa-
mine observed in this model of fructose overload in 
the diet and a depression in the ANP system. Simi-
larly, it can be postulated that the alteration of both 
systems would be associated with the development of 
renal damage, taking into account that this preceded 
the appearance of renal structural injury evidenced by 
microalbuminuria at week 12 of fructose treatment.
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